Our previous studies have demonstrated the explicit anti‐cancer role of KLF4 in BCa,24 which has also been acknowledged in other urologic cancers, such as prostate cancer26 and renal cancer.27 Therefore, we focused on exploring the mechanism of SETD7. This evidence concerns the gene KLF4 and renal carcinoma.